Cetuximab/Irinotecan/Vemurafenib Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C153480
A chemoimmunotherapy regimen consisting of cetuximab, irinotecan and vemurafenib that can be used for the treatment of colon cancer. [ ]
Term info
Label
Cetuximab/Irinotecan/Vemurafenib Regimen
Synonyms
- Cetuximab-Irinotecan-Vemurafenib
- Cetuximab-Irinotecan-Vemurafenib Regimen
- Cetuximab/Irinotecan/Vemurafenib
- Cetuximab/Irinotecan/Vemurafenib Regimen
- Irinotecan + Cetuximab + Vemurafenib
- Irinotecan + Cetuximab + Vemurafenib Regimen
- Irinotecan/Cetuximab/Vemurafenib
- Irinotecan/Cetuximab/Vemurafenib Regimen
Subsets
NCIT_C160952, NCIT_C160950
DesignNote
NCCN guidelines 2018
NCI META CUI
CL554979
Preferred Name
Cetuximab/Irinotecan/Vemurafenib Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C153480